These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11956885)

  • 21. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term lithium therapy leading to hyperparathyroidism: a case report.
    Rizwan MM; Perrier ND
    Perspect Psychiatr Care; 2009 Jan; 45(1):62-5. PubMed ID: 19154241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tardive dyskinesia in a neuroleptic-naive patient with bipolar-I disorder: persistent exacerbation after lithium intoxication.
    Meyer-Lindenberg A; Krausnick B
    Mov Disord; 1997 Nov; 12(6):1108-9. PubMed ID: 9399254
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lithium, a potentially dangerous drug].
    Yo MS; Rommes JH; Spronk PE; Janssen JC
    Ned Tijdschr Geneeskd; 2005 Feb; 149(6):273-6. PubMed ID: 15730030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium-induced Hashimoto's encephalopathy: a case report.
    Nagamine M; Yoshino A; Ishii M; Ogawa T; Kurauchi S; Yoshida T; Shigemura J; Kodera T; Tanaka Y; Nomura S
    Bipolar Disord; 2008 Nov; 10(7):846-8. PubMed ID: 19032717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lithium, a potentially dangerous drug].
    Dhondt AD
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):1017; author reply 1018-9. PubMed ID: 15903045
    [No Abstract]   [Full Text] [Related]  

  • 28. FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy.
    De Smet E; Rioux JP; Ammann H; Déziel C; Quérin S
    Nephrol Dial Transplant; 2009 Sep; 24(9):2938-40. PubMed ID: 19509024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.
    Peters HP; van de Kar NC; Wetzels JF
    Neth J Med; 2008 Nov; 66(10):408-15. PubMed ID: 19011266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of refractoriness to lithium therapy following its discontinuation in a previously responsive patient.
    Appleby B; Wise T; Isaac A
    Harv Rev Psychiatry; 2006; 14(6):330-2. PubMed ID: 17162656
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lithium, a potentially dangerous drug].
    Wentges-van HJ
    Ned Tijdschr Geneeskd; 2005 Nov; 149(48):2700. PubMed ID: 16358622
    [No Abstract]   [Full Text] [Related]  

  • 32. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lithium, a potentially dangerous drug].
    Monnens LA; Levtchenko E
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):1019; author reply 1019. PubMed ID: 15903049
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
    Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
    Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lithium, a potentially dangerous drug].
    Zwaard A
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):1018; author reply 1018-9. PubMed ID: 15903047
    [No Abstract]   [Full Text] [Related]  

  • 36. Lithium-induced sinus node dysfunction at therapeutic serum levels.
    Singh LK; Praharaj SK; Munda SK; Khess CR
    Natl Med J India; 2011; 24(3):151-2. PubMed ID: 21786844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Important hypercalcaemia due to hyperparathyroidism induced by lithium].
    Lions C; Precloux P; Burckard E; Soubirou JL; Escarment J
    Ann Fr Anesth Reanim; 2005 Mar; 24(3):270-3. PubMed ID: 15792560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lithium, a potentially dangerous drug].
    van der Goot B; Hagen EC; Keet IP; Wernand J
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):1018; author reply 1018-9. PubMed ID: 15903048
    [No Abstract]   [Full Text] [Related]  

  • 39. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lithium in the long-term treatment of bipolar disorders.
    Kleindienst N; Greil W
    Eur Arch Psychiatry Clin Neurosci; 2003 Jun; 253(3):120-5. PubMed ID: 12904975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.